Pharmafile Logo
Pharmafocus logo
Advanced Search
lilly_entrance_web

Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials

February 18, 2021
Eli Lilly, diabetes

Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …

News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

February 17, 2021
Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup

The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …

News

J&J’s one-shot COVID-19 vaccine submitted to the EU

February 17, 2021
Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine

Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.

News
lynparza

AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival

February 17, 2021
Research and Development AstraZeneca, Cancer, MSD

The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …

News

Novartis and Gates Foundation join forces on sickle cell disease research

February 17, 2021
Research and Development Novartis, sickle cell disease

Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …

News

FDA approves Novartis’ heart failure drug Entresto

February 17, 2021
Research and Development FDA, Novartis

The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …

News

North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data

February 16, 2021
Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine

North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …

News

South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines

February 16, 2021
Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea

South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.

News
who_flag

WHO approves two versions of AstraZeneca’s COVID-19 vaccine

February 16, 2021
Manufacturing and Production AstraZeneca, COVID-19, WHO

The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …

News
enhertu

Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu approved in UK

February 16, 2021
Manufacturing and Production AstraZeneca, Cancer, Daiichi Sankyo

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted conditional authorisation in the UK as a monotherapy for the …

News
image_readtop_2018_569751_15365546683454581

Celltrion’s inflammatory disease drug Yuflyma gets EU approval for 13 indications

February 16, 2021
Manufacturing and Production EC, celltrion

The European Commission (EC) has granted marketing authorisation for Celltrion’s Yuflyma, an adalimumab biosimilar, across all thirteen intended indications for …

News
Eli Lilly front sign

University of Glasgow and Lilly sign £4.6m immunological disease partnership

February 15, 2021
Sales and Marketing Eli Lilly, University of Glasgow, arthritis, fibrosis, lilly, uofg

The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …

News

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021
Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …

News
astrazeneca_sign_sky

AstraZeneca’s COVID-19 vaccine to be trialled in children

February 15, 2021
Sales and Marketing AstraZeneca, COVID-19

The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …

News

Genentech’s injectable eye medicine extends time between treatments for two conditions

February 15, 2021
Sales and Marketing Genentech

Genentech has announced detailed, positive results from four Phase III studies of its investigational bispecific antibody, faricimab, for the treatment …

News

Molecular Templates signs cancer deal with BMS worth up to $1.3bn

February 15, 2021
Sales and Marketing Bristol-Myers Squibb, bristol myers squibb

Molecular Templates and Bristol Myers Squibb have entered into a worldwide strategic research collaboration worth up to $1.3 billion, to …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 12, 2021
Medical Communications

Over the past week, AstraZeneca’s COVID-19 jab has been at the centre of disputes about vaccine efficiency both in older …

News
opdivo_1_1

NICE recommends Bristol Myers Squibb’s skin cancer drug Opdivo for NHS use

February 12, 2021
Medical Communications Bristol-Myers Squibb, NICE, bristol myers squibb

NICE has issued final draft guidance recommending the routine use of Bristol Myers Squibb (BMS)’s Opdivo (nivolumab) as an option …

News
who_flag

AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances

February 12, 2021
Medical Communications AstraZeneca, COVID-19

Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …

News
ipos0_l

FDA approves Regeneron’s Evkeeza for HoFH

February 12, 2021
Medical Communications FDA, Regeneron

The FDA has approved Regeneron’s Evkeeza (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026